EMEDZ.NET

Disclaimer Notice:

Dear Readers! I started this blog when my daughter was in the NICU. She had ventriculitis. Her CSF report grew E.coli. But, she was injected Teicoplanin directly into her brain. The doctors made two errors here:

Teicoplanin is for gram-positive bacteria only. It does not treat E.coli.
Teicoplanin is not for intraventricular use. The manufacturer strongly discourage injecting Teicoplanin into the brain.

My daughter bled into the brain. She lived for another two years and ultimately died.

The information provided on Emedz.net is for doctors and pharmacists only to manage their patients in the best way and avoid medications-related errors.

Still, for the general population, this should not be considered professional medical advice or a substitute for consultation with a licensed healthcare provider. The content on this blog is not intended to diagnose, treat, cure, or prevent any disease or health condition.

Always seek the advice of a qualified healthcare professional before making any changes to your diet, exercise routine, medication, or any other aspect of your healthcare. We strongly discourage self-medication and self-treatment.

Even though the primary author of emedz.net is an experienced health professional, the blog is not intended to replace medical advice sought at the Doctor’s Clinic.

The authors share personal experiences, research findings, and general knowledge about health and wellness and medications-related topics.

However, individual health situations vary, and what works for one person may not work for another. It's important to consult with a healthcare provider for personalized guidance.

We strive to provide accurate and up-to-date information, but medical knowledge is constantly evolving. Therefore, we do not guarantee the accuracy, completeness, or timeliness of the information presented in this blog.

Emedz.net is not an online pharmacy:

Online pharmacies sell medicines and pharmaceutical products. EMEDZ.net is intended to provide drug-related information to pharmacists and physicians. It is intended to provide authentic information about medicines so as to prevent errors related to prescriptions.

We do not sell medicines, so please don’t ask for them.

We are not affiliated with any pharmaceutical companies:

Emedz.net has no affiliation with any pharmaceutical companies. We do not promote any product. Sometimes brand names are also mentioned in the title of the page, but that is what is called a “Featured Image”. It has nothing to do with selling or promoting that brand. Just to make things easier, generic and brands are mentioned in the blog.

Emedz.net may contain links to external websites or resources for your convenience. We do not endorse or take responsibility for the content of these external sites.

In no event shall Emedz.net, its authors, contributors, or any related parties be liable for any damages or consequences arising from the use of the information provided on this blog.

By using Emedz.net, you acknowledge and agree to this disclaimer and our Terms of Use. If you do not agree with this disclaimer or our Terms of Use, we advise you to refrain from using our website.

Remember, your health is a valuable asset, and decisions about your health should always be made in consultation with a qualified healthcare professional.

Desoximetasone (Topicort) - Uses, Dose, Side effects, MOA, Brands

Desoximetasone (Topicort), a topical corticosteroid of medium to high potency, is used to treat the symptoms of plaque psoriasis and eczema in patients.

Desoximetasone Uses:

Cream, gel, and ointment:
- It is prescribed to treat the inflammatory and itchy symptoms of dermatoses that respond to corticosteroids.
Spray:
- Plaque psoriasis treatment.

Desoximetasone (Topicort) Dose in Adults

Note: The treatment should be discontinued as soon as the condition improves. If no improvement is noted after 4 weeks of the treatment, the diagnosis should be reassessed.

Desoximetasone (Topicort) Dose in the therapy of Corticosteroid-responsive dermatoses:

Topical: Cream, gel, ointment:
- Two times each day, apply a thin coating to the afflicted region.

Desoximetasone (Topicort) Dose in treatment of Plaque psoriasis:

Topical: Spray:
- Two times each day, apply a thin coating to the afflicted region.

Desoximetasone (Topicort) Dose in Children

Note:

It is advised to use the least amount necessary for the shortest amount of time. Depending on the affected area and the disease's severity, the dose may change.
When the situation gets better, the therapy should be stopped. If no progress is seen after receiving therapy for four weeks, patients may need to be reevaluated.

Desoximetasone (Topicort) Dose in the treatment of steroid-responsive dermatoses including contact dermatitis and atopic dermatitis:

Cream/gel: Children and Adolescents:
- Two times each day, apply a thin coating to the afflicted region.
Ointment: Children ≥10 years and Adolescents:
- Two times each day, apply a thin coating to the afflicted region.

Pregnancy Risk Factor C

Corticosteroids have been shown to be teratogenic in animal reproduction studies.
While topical corticosteroids are not a risk to the fetus in humans, they can cause intrauterine growth retardation.
Pregnant females should avoid long-term use and applications over a greater surface area.

Use during breastfeeding:

Human breastmilk contains systemic corticosteroids.
Although it is unknown how much drug is absorbed from topical application, neonatal hypertension has been caused by the application of systemic corticosteroids to the nipples of lactating mothers. Breastfeeding infants should not use it.

Dose in Kidney Disease:

There are no dosage adjustments provided in the manufacturer’s labeling.

Dose in Liver disease:

There are no dosage adjustments provided in the manufacturer’s labeling.

Common Side Effects of Desoximetasone (Topicort):

Endocrine & metabolic:
- HPA-axis suppression
- Cushings syndrome
Others:
- Infections (Bacterial and Fungal)
- Skin atrophy

Contraindications to Desoximetasone (Topicort):

Cream, gel, ointment:

Allergy to desoximetasone and any component of the formulation

Spray:

The manufacturer's labeling does not list any contraindications.

Warnings and precautions

Suppression of the adrenals:
- Extended use can result in suppression of cortisol endogenous secretion via HPA suppression
- HPA suppression is more common in children younger than those who have been treated for a long time. In stress-like situations, patients may experience adrenal crisis.
Contact dermatitis:
- Allergy contact dermatitis can be diagnosed in patients who have not healed from their primary lesion.
Immunosuppression:
- Topical use can lead to the development of superinfections due to immunosuppression. You should stop using the topical and get antimicrobial treatment.
Kaposi's Sarcoma:
- Kaposi's Sarcoma case reports have been published using topical corticosteroids. If suspected, treatment must be stopped immediately.
Reactions to skin:
- Local skin reactions can occur from topical application, such as striae, telangiectasias and atrophic skin.
- Patients who are exposed to higher doses of medication, those wearing occlusive dressings or for extended periods of time may experience local reactions that may not be reversed.
Systemic effects
- Patients may experience systemic absorption. This can lead to side effects such as Cushing's syndrome or secondary diabetes.
- Occlusive dressings are applied over large areas and on skin that is not denuded to increase systemic absorption.
Skin infections
- Long-term treatment may lead to superinfections. It is possible that the treatment must be stopped.
- Antifungals and antibiotics should be used to treat the patient as appropriate.

Desoximetasone: Drug Interaction

Note: Drug Interaction Categories:

Risk Factor C: Monitor When Using Combination
Risk Factor D: Consider Treatment Modification
Risk Factor X: Avoid Concomitant Use

Risk Factor C (Monitor therapy).
Corticorelin	Corticosteroids can reduce the therapeutic effects of Corticorelin. Recent or current corticosteroid treatment may affect plasma ACTH responses to Corticorelin.
Deferasirox	Corticosteroids can intensify Deferasirox's hazardous or harmful effects. Particularly, there may be a higher risk of GI bleeding or ulcers.
Ritodrine	Ritodrine's toxic/adverse effects may be exacerbated by corticosteroids. Risk C: Monitor
Risk Factor D (Consider therapy modifications)
Hyaluronidase	The therapeutic effects of Hyaluronidase may be diminished by corticosteroids. Management: Patients who are taking corticosteroids, especially at higher doses, may not have the desired clinical response to standard doses hyaluronidase. Higher doses of hyaluronidase might be necessary.
Risk Factor X (Avoid Combination)
Aldesleukin	Aldesleukin's antineoplastic effects may be diminished by corticosteroids.

Monitoring parameters:

Monitor for the response to treatment.
Monitor for HPA suppression and features of Cushing's syndrome in patients on long-term glucocorticoid treatment.
Observe for skin atrophy and monitor for superinfections (bacterial or fungal infections).

How to administer Desoximetasone (Topicort)?

Topical:

It is only intended for usage outside.
Wash your hands well before and after applying the medication.
If not instructed to do so by a professional, avoid using occlusive dressings.
Apply to dry, clean skin and gently massage in.

Spray:

Avoid applying the medicine over the face, axilla, groin, atrophic skin, or mucous membranes.
Avoid heat, flame, or smoking when applying the medicine (it is flammable).
Discard the unused medicine after 30 days.

Cream, gel, and ointment:

Avoid any contact with your eyes

Mechanism of action of Desoximetasone (Topicort):

It is a synthetic medium-high potency glucocorticoid.
It binds to intracellular cells and modifies gene expression.
It prevents the production and release endogenous chemical mediators like kinins and prostaglandins.
It is anti-inflammatory, antipruritic and antiallergic.
It can be used in combination with other drugs to treat steroid-responsive skin diseases.